These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35 related articles for article (PubMed ID: 1615806)
1. A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial. Bertrand OF; Poirier P; Rodés-Cabau J; Rinfret S; Title L; Dzavik V; Natarajan M; Angel J; Batalla N; Alméras N; Costerousse O; De Larochellière R; Roy L; Després JP; Can J Cardiol; 2009 Sep; 25(9):509-15. PubMed ID: 19746240 [TBL] [Abstract][Full Text] [Related]
2. [Assessment of saphenous vein graft wall characteristics with intravascular ultrasound imaging]. Kobayashi T; Makuuchi H; Naruse Y; Sato T; Fujiki T; Ninomiya M; Ogata K; Komiyama N Jpn J Thorac Cardiovasc Surg; 1998 Aug; 46(8):701-6. PubMed ID: 9785866 [TBL] [Abstract][Full Text] [Related]
3. Acute and long-term outcome of narrowed saphenous venous grafts treated by endoluminal stenting and directional atherectomy. Pomerantz RM; Kuntz RE; Carrozza JP; Fishman RF; Mansour M; Schnitt SJ; Safian RD; Baim DS Am J Cardiol; 1992 Jul; 70(2):161-7. PubMed ID: 1626501 [TBL] [Abstract][Full Text] [Related]
4. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. Safian RD; Grines CL; May MA; Lichtenberg A; Juran N; Schreiber TL; Pavlides G; Meany TB; Savas V; O'Neill WW Circulation; 1994 Jan; 89(1):302-12. PubMed ID: 8281662 [TBL] [Abstract][Full Text] [Related]